Register Now
Course Information

Join us at WASOG/AASOG 2020

This international conference is the leading scientific event of the World Association for Sarcoidosis and Other Granulomatous Disorders and Americas Association for Sarcoidosis and Other Granulomatous Disorders. The scientific program of the conference includes the latest information regarding the pathogenesis, diagnosis and treatment of sarcoidosis and interstitial lung diseases. Internationally recognized experts will share their experience with us during this 4-day scientific event.

By attending this conference, participants will be able to:

  • Summarize the evidence on managing patients with fibrotic interstitial lung disease including diagnostic techniques and antifibrotic and immunosuppressive therapies.
  • Clinically review the diagnostic dilemmas, utility of diagnostic testing, and usefulness of therapies to identify and manage cardiac sarcoidosis.
  • Describe how granulomatous and nongranulomatous inflammation leads to fibrosis.
  • Review the current knowledge of genetics and genomics in sarcoidosis and interpret its implications for clinical practice.
  • Review efficacy and side effect profiles for treatments used to manage sarcoidosis.
  • Define disability in sarcoidosis using WASOG criteria and describe instruments for assessment, survey results, and occupational medicine perspectives.

Who Should Attend?

Practitioners and healthcare professionals who seek to learn the latest developments in sarcoidosis and interstitial lung diseases, including pulmonologists, cardiologists, pulmonary critical care specialists, nurse practitioners, residents and fellows.

Abstract Competition

The WASOG/AASOG 2020 Scientific Committee invites medical professionals and trainees (including fellows, residents, and medical students) to submit clinical and/or research abstracts for consideration for poster presentations on Thursday, June 25. The top abstract submissions will be invited for oral presentations on Friday, June 26. Click here for complete details.